Publisher
Springer Berlin Heidelberg
Reference85 articles.
1. Allain J, Gazengel C, Sultan Y, Verroust F, and the French Hemophilia Study Group (1986) Clinical evaluation of a heat-treated high-purity factor VIII concentrate. Ricerca 16: 245
2. Allain JP, Dailey SH, Laurian Y, Vallari DS, Rafowicz A, Desai SM, Devare SG (1991) Evidence for persistent hepatitis C virus (HCV) infection in hemophiliacs. J Clin Invest 88(5): 1672–1679
3. Azimi PH, Roberto RR, Guralnik J, Livermore T, Hoag S, Hagens S, Lugo N (1986) Transfusion-acquired hepatitis A in a premature infant with secondary nosocomial spread in an intensive care nursery. Am J Dis Child 140(1): 23–27
4. Azzi A, Ciappi S, Zakrzewska K, Morfini M, Mariani G, Mannucci PM (1992) Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated factor VIII concentrates. Am J Hematol 39(3): 228–230
5. Berntorp E, Nielsson IM, Ljung R, Wide11 A (1990) Hepatitis C virus transmission by monoclonal antibody purified factor VIII concentrate [letter]. Lancet 335: 1531–1532